| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Revenue | $66.2M | +1.9% |
| Cost of Revenue | $33.7M | +4.5% |
| Gross Profit | $32.5M | -0.6% |
| R&D Expense | $8.7M | +22.2% |
| SG&A Expense | $13.7M | +12.3% |
| Operating Income | $10.1M | -24.7% |
| Pre-tax Income | $12.5M | -14.8% |
| Income Tax | -$20.7M | — |
| Net Income | $33.2M |
| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $49.2M | +63.6% |
| Short-term Investments | $0 | -100.0% |
| Inventory | $37.5M | +56.7% |
| Current Assets | $97.8M | +9.9% |
| Total Assets | $127.9M | +30.3% |
| Current Liabilities | $10.5M | -35.6% |
| Total Liabilities | $16.3M | -27.6% |
| Line Item | 2024-05-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.8M | -82.5% |
| Capital Expenditures | $749K | -45.0% |
| Investing Cash Flow | $17.3M | +192.5% |
| Financing Cash Flow | $139K | -98.1% |
| Free Cash Flow | $1.0M | -88.4% |
| +127.8% |
| EPS (Basic) | $1.15 | +121.2% |
| EPS (Diluted) | $1.12 | +124.0% |
| Stockholders' Equity |
| $111.6M |
| +47.6% |